Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff(Roche (Switzerland)), Gerard Drewes(Unknown), Gavain M.A. Sweetman(GlaxoSmithKline (Germany)), Carola Huthmacher, Paola Grandi(GlaxoSmithKline (Germany)), Katja Strunk, Yann Abraham, Toby Mathieson, Valérie Reader(Chelmsford and Essex Hospital), Antje Dittmann(University of Zurich), Markus Böesche, Dirk Eberhard(Karolinska Institutet), Giovanna Bergamini(Heidelberg Engineering (Germany)), Manja Delling, Nigel G. Ramsden(CellCentric (United Kingdom)), Gitte Neubauer, Judith Schlegl(Systems, Applications & Products in Data Processing (Germany)), Carsten Hopf(Technische Hochschule Mannheim), Ulrich Kruse, Isabelle Becher, Daniel Poeckel, Birgit Dümpelfeld, Anne‐Marie Michon, Mikhail M. Savitski(European Molecular Biology Laboratory)
Cited by 666
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801